SCHEMBL20042742

SCHEMBL20042742

Cc1cc(C(=O)N2Cc3nc(C)nc(N4CCC4)c3[C@H]2C)cc(C)n1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PROKR1 Q8TCW9 1/20 0.35
KDM4E B2RXH2 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TP53 P04637 2/20 0.32
POLB P06746 1/20 0.32
HSD17B10 Q99714 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KMT2A Q03164 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
MAPK1 P28482 1/20 0.32
P2RX7 Q99572 1/20 0.32
TACR3 P29371 3/20 0.31
NPY5R Q15761 3/20 0.31
KCNH2 Q12809 2/20 0.31
GBA1 P04062 3/20 0.31
THRB P10828 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
TACR2 P21452 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20042869 0.88 PROKR1 (0.41) PROKR1KDM4ESMN1; SMN2HSD17B10P2RX7
SCHEMBL20042868 0.86 P2RX7 (0.35) KDM4ESMN1; SMN2TP53POLBMEN1
SCHEMBL20042982 0.84 P2RX7 (0.46) SMN1; SMN2TP53POLBHSD17B10ALDH1A1
SCHEMBL20042958 0.84 TACR3 (0.42) TACR3KCNH2TACR2
SCHEMBL20042865 0.84 TACR3 (0.42) TACR3KCNH2TACR2
SCHEMBL20042851 0.84 P2RX7 (0.46) SMN1; SMN2TP53POLBHSD17B10ALDH1A1
SCHEMBL20042986 0.84 TAS1R3 (0.40) TP53P2RX7TACR3KCNH2THRB
SCHEMBL20042876 0.84 TAS1R3 (0.40) TP53P2RX7TACR3KCNH2THRB
SCHEMBL20043019 0.84 POLB (0.34) KDM4ETP53POLBHSD17B10MEN1
SCHEMBL20042857 0.84 PROKR1 (0.35) PROKR1KDM4ESMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed